Sun Pharma Advanced Research Company Q1 net loss at Rs 2.51 cr

Tags: Companies
Sun Pharma Advanced Research Company today reported a net loss of Rs 2.51 crore for the first quarter ended March 31, 2014, mainly on account of increase in expenses during the period.

The company had posted a net profit of Rs 44.04 crore during the same period of previous fiscal, Sun Pharma Advanced Research Company Ltd (SPARC) said in a statement.

Total income of the company declined to Rs 42.57 crore during the first quarter, as compared to Rs 71.83 crore in the same period of previous fiscal.

The company's expenses during the quarter rose by 78.43 per cent to Rs 48.16 crore in the first quarter, as against Rs 26.99 crore during the same period of previous fiscal.

SPARC was demerged from Sun Pharmaceutical Industries Ltd as a research and drug discovery company in 2007.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • With RBI’s role diluted, we are moving closer towards a super regulator

    The government and the Reserve Bank of India (RBI) have signed a monetary policy framework agreement last month under which RBI will be committed to b

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Roopen Roy

The making of a digital Bharat

Exactly 20 years ago, Nicholas Negroponte of MIT Media Labs ...

Rajgopal Nidamboor

The eternal radiance of our being

We sense, we sight, we smell, we touch, we hear, ...

Shona Adhikari

Art world celebrates two ‘new’ Cezannes

The focus moves once more to post-impressionist Paul Cezanne, who ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture